AIM
ELV icon

abrdn Investment Management’s Elevance Health ELV Stock Holding History

abrdn Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,078
Closed -$1.39M – 272
2014
Q4 		$1.39M Sell
11,078
-390
-3% -$48.2K 0.01% 222
2014
Q3 		$1.37M Sell
11,468
-398
-3% -$45.6K 0.01% 255
2014
Q2 		$1.28M Buy
+11,866
New +$1.22M 0.01% 261
2013
Q4 		– Sell
-12,814
Closed -$1.07M – 504
2013
Q3 		$1.07M Sell
12,814
-196
-2% -$16.8K 0.01% 249
2013
Q2 		$1.06M Buy
+13,010
New +$974K 0.01% 233

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

abrdn Investment Management's ELV Position: Q1 2015 in Review

abrdn Investment Management sold out of Elevance Health (ELV) in Q1 2015, closing a stake of 11,078 shares — an estimated $1.39M sold.

abrdn Investment Management first reported a position in ELV in Q2 2013 and held it in 5 quarters. The position peaked at $1.39M in Q4 2014. 752 funds tracked by Wall St. Rank hold ELV as of Q1 2015.

  • abrdn Investment Management reported no remaining Elevance Health position as of Q1 2015 after selling out during the quarter.
  • abrdn Investment Management sold 11,078 Elevance Health shares in Q1 2015, an estimated $1.39M.
  • abrdn Investment Management first reported a position in Elevance Health in Q2 2013 and held it in 5 quarters.
  • abrdn Investment Management's Elevance Health position peaked at $1.39M in Q4 2014.
  • 752 funds tracked by Wall St. Rank held Elevance Health as of Q1 2015.

Based on abrdn Investment Management's 13F filing for Q1 2015, filed 15 May 2015.